TITLE

Respira Therapeutics Announces Results of Proof-of-Concept Study in Humans

PUB. DATE
June 2011
SOURCE
Biomedical Market Newsletter;6/30/2011, p671
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the results announced by Respira Therapeutics Inc. regarding a clinical feasibility study of its drug engine technology (DET) called dry powder inhaler (DPI) for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It notes that the patented DPI drug engine of the company delivers inhaled medications to the diseased lung at three to four times the rate of existing inhalers. An overview about Respira Therapeutics is also presented.
ACCESSION #
62253463

 

Related Articles

  • Inhaler use for COPD needs closer monitoring in LTC.  // Canadian Nursing Home;Oct/Nov2013, Vol. 24 Issue 3, p21 

    No abstract available.

  • Effect of Variable Inspiratory Flow Rate on the Performance of the Budesonide Rhinocort Turbuhaler. devalia, J.L.; Prime, D.; Richards, D.H. // Clinical Drug Investigation;2001, Vol. 21 Issue 3, p195 

    Objective: To investigate the effect of variable nasal inspiratory flow rates in vitro on total drug delivery and deposition patterns of budesonide delivered from the Rhinocort Turbuhalerâ„¢. Methods: The total dose of budesonide delivered at flow rates of 15, 30 and 60 L/min and the...

  • Control particle size and morphology with this technique.  // Chemical Engineering;Oct2013, Vol. 120 Issue 10, p12 

    The article reports on the development of an antisolvent vapor precipitation (AVP) technique as of October 2013, for the control of lactose particle size and morphology, which may improve the efficiency of powder pulmonary-drug delivery, as in the case of asthma inhalers.

  • COPD Inhaler Selection - Factors to Consider. Straw, Andrew; Heins, Jodi R.; Evers, Meredith // South Dakota Medicine;May2015, Vol. 68 Issue 5, p217 

    The article discusses the factors to be considered while selecting inhalers for the treatment of chronic obstructive pulmonary disease (COPD). Topics discussed include consideration of the patient's adherence to the device, availability of different types of inhalers such as dry powder inhalers,...

  • Choosing the Right Inhaled Medication Device for COPD. RAY, SHAUNTA' M.; STEVENS, AMY R. BARGER // American Family Physician;11/15/2013, Vol. 88 Issue 10, p650 

    The authors discuss research on inhaled medication device for chronic obstructive pulmonary disease (COPD). They reference the study "Treatment of Stable COPD: The GOLD Guidelines" by H. Lee and colleagues published in the current issue of the journal. They discuss the prevalence of COPD, the...

  • 17 RESPIRATORY DISORDERS 17A Asthma/COPD.  // Monthly Prescribing Reference;Oct2016, Vol. 32 Issue 10, p238 

    The article offers information on the medications for the treatment of asthma and chronic obstructive pulmonary disorder (COPD) from different pharmaceutical companies. It mentions its indications and symptoms, contraindications and precautions for each medications. Moreover, it also cites the...

  • Archimedes: QUESTION 3. Burrill, Rianna; Carroll, Will // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Sep2009, Vol. 94 Issue 9, p11 

    The article presents a medical case of a 6-year-old girl with asthma. She has been in the hospital in the last two years and was prescribed with 200 μg per day of inhaled budesonide while she takes salbutamol three-four times a week. It presents a question whether there is a written...

  • Which Inhaler Combination is Best for COPD Treatment? Elliott, William T. // Clinical Cardiology Alert;Apr2007 Pharmacology Watch, p1 

    The article focuses on two studies that have looked at the effects of various inhaler combinations on outcomes in patients with chronic obstructive pulmonary disease (COPD). The first study from British researchers compared the use of salmeterol plus fluticasone inhaler twice daily with...

  • Coping with Your COPD: Good Advice from a Respiratory Therapist. Stegmaire, Jim // AARC Times;Jul2013, Vol. 37 Issue 7, p124 

    The article presents answers to questions about the need to use a respiratory spacer (RS) when taking an inhaler, and information on static-free RS.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics